Emcure Pharmaceuticals partners with Sanofi India to distribute and promote oral anti-diabetic products in India.

Pharma giants like Cipla, Glenmark, and Emcure are stepping into the booming skincare market, challenging beauty brands with ...

Emcure Pharmaceuticals and Sanofi India have partnered in an exclusive distribution and promotion agreement for Sanofi's oral ...

Over 100 million Indians are living with type 2 diabetes and its complexities in India,' said Eric Mansion from Sanofi.

Emcure Pharmaceuticals and Sanofi India announce exclusive distribution agreement for Sanofi's oral anti-diabetic products in ...

The Board of Directors, acting on the recommendation of the Nomination and Remuneration Committee, has approved the appointment of Mr. Rachid Ayari (DIN: 10408699) as the Interim Managing Director of ...

Emcure Pharmaceuticals made its market debut on July 10, 2024. The shares of the Pune-based company have risen 27% against ...

Emcure Pharmaceuticals IPO listing date has been scheduled for tomorrow (Wednesday, July 10). IPO GMP is heading upward and is expected to have a solid listing based on the actions of the past 13 ...

Emcure Pharma IPO price band The IPO is priced in the range of Rs 960-1008 per share, where investors can bid for 14 shares in one lot. At the upper end, the company plans to raise Rs 1952 crore ...

Generic drugmaker Emcure Pharmaceuticals convinced a federal court in Seattle, Washington, on Monday to throw out a lawsuit that accused it of stealing trade secrets from biopharma company HDT Bio ...

Global investment firm Bain Capital on Friday divested a 2.4 per cent stake in Emcure Pharmaceuticals for Rs 563 crore through an open market transaction. Following the stake sale, shares of Emcure ...

Emcure Pharmaceuticals and Sanofi India have entered in a partnership to distribute and promote Sanofi’s oral anti-diabetic ...